The Institute for Clinical and Economic Review (ICER) on Tuesday, April 2, announced Pamela Bradt would serve as the organization’s chief science officer.
According to a press release, Bradt will lead research initiatives and play a key role in helping “evolve ICER’s methods of value assessment and expand the application of our work.”
“We are thrilled to have Dr. Bradt join ICER’s leadership team as Chief Scientific Officer,” ICER President Steven Pearson said in a statement. “Her expertise … will help ICER continue to nudge the US health system toward fair pricing, fair patient access, and continued incentives for future innovation.”
Bradt in a statement said she looked forward to “following where the evidence leads, and contributing to ICER’s mission of helping all Americans achieve sustainable access to high-value care.”
To read the full press release on ICER’s website, click here.